Edgewise Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Edgewise Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Edgewise Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Edgewise Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $2.5M | 92k | 26.70 |
2024-09-30 | $2.0M | 75k | 26.69 |
2024-06-30 | $1.1M | 61k | 18.01 |
2024-03-31 | $1.4M | 74k | 18.24 |
2022-12-31 | $14k | 1.6k | 8.94 |
2022-03-31 | $214k | 22k | 9.71 |
2021-06-30 | $19k | 868 | 21.89 |